Männistö, Pekka T.
Keränen, Tapani
Reinikainen, Kari J.
Hanttu, Anna
Pollesello, Piero http://orcid.org/0000-0001-6994-768X
Article History
Received: 4 April 2024
Accepted: 2 May 2024
First Online: 29 May 2024
Declarations
:
: Pekka T. Mannisto, Tapani Keranen and Kari J. Reinikainen have been full- or part-time employees of Orion Pharma and worked on the discovery and development of entacapone and/or Stalevo. In the past 5 years all three have received honoraria from Orion Pharma for educational and promotional consultancies. Anna Hanttu and Piero Pollesello are current full-time employees of Orion Pharma. None of the co-authors have other financial interests in Orion Pharma.
: This article is based on previously conducted studies and does not contain any new studies with human participants or animals performed by any of the authors.